Press Release | Mon May 6, 2013 9:00am EDT

Medtronic Announces FDA Approval of New Portfolio of Next-Gen Cardiac Resynchronization Therapy Devices, Implantable Cardioverter-Defibrillators

* Reuters is not responsible for the content in this press release.